Isomorphic Labs raised $5 billion to expand its AI drug design platform and move its first drug candidates toward human trials after a $2.1 billion May round.
The post $7.1 Billion in Six Months: Isomorphic Labs Builds Toward Its First Human Trials appeared first on TechRepublic.
Advertisement
Be the first to comment